Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulphate in PENG Block for Hip Surgery
NCT06180031Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of magnesium sulfate in hip fracture (2 arms), sponsored by Assiut University. Primary endpoint: Total amount of postoperative morphine consumption at 24 hours. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT06180031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06180031.